Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Hess CN, Szarek M, Anand SS, Bauersachs RM, Patel MR, Debus ES, Nehler MR, Capell WH, Beckman JA, Piazza G, Henkin S, Bura-Rivière A, Lawall H, Roztocil K, Hsia J, Muehlhofer E, Berkowitz SD, Haskell LP, Bonaca MP.
Hess CN, et al. Among authors: lawall h.
JAMA Netw Open. 2022 Jun 1;5(6):e2215580. doi: 10.1001/jamanetworkopen.2022.15580.
JAMA Netw Open. 2022.
PMID: 35731517
Free PMC article.
Clinical Trial.